Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 7/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.37 |
| ▸ | MDM4 | O15151 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TTR | P02766 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14982025 | 0.81 | HCAR2 (0.47) | HCAR2MAPTATMCA12CA1 | |
| SCHEMBL18561871 | 0.79 | HCAR2 (0.52) | HCAR2MAPTATMCA12CA1 | |
| SCHEMBL11800873 | 0.79 | HCAR2 (0.52) | HCAR2MAPTATMCA12CA1 | |
| SCHEMBL18561872 | 0.79 | HCAR2 (0.52) | HCAR2MAPTATMCA12CA1 | |
| SCHEMBL11800870 | 0.79 | HCAR2 (0.52) | HCAR2MAPTATMCA12CA1 | |
| SCHEMBL691282 | 0.78 | HCAR2 (0.56) | HCAR2MAPTATMCA12CA1 | |
| SCHEMBL104920 | 0.78 | HCAR2 (0.56) | HCAR2MAPTATMCA12CA1 | |
| SCHEMBL8582836 | 0.78 | HCAR2 (0.56) | HCAR2MAPTATMCA12CA1 | |
| SCHEMBL15197522 | 0.77 | HCAR2 (0.43) | HCAR2MAPTATMCA12CA1 | |
| SCHEMBL17297226 | 0.77 | HCAR2 (0.43) | HCAR2MAPTATMCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160168195-A1 | OLIGOPEPTIDES AND PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168195-A1 | OLIGOPEPTIDES AND PROCESS FOR PREPARATION THEREOF | NGLY1, VIP, PREP | HCAR2 4798/4885MAPT 3876/4885ATM 4270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.